Enhancing Large-Scale Data Quality And Compliance: How Medrio Empowers Freenome

Freenome, a pioneering biotech company focused on developing next-generation blood tests for early cancer detection, was faced with the monumental task of running large-scale clinical trials to achieve their vision of detecting cancer in its earliest, most treatable stages. This study would easily involve hundreds of sites, thousands of participants, and a vast amount of data. However, handling data capture, patient-reported outcomes (PROs), and consent in such large-scale trials carried inherent risks related to patient safety, data quality, and site coordination.

To address these challenges without compromising patient centricity or study performance, Freenome turned to Medrio. By leveraging Medrio's CDMS/EDC, eCOA/ePRO, and eConsent solutions, Freenome was able to ensure quality, compliant data collection across their three clinical trials involving over 60,000 participants and more than 200 sites.

Get all the details of this success story by delving into the five key ways Medrio was able to empower Freenome to achieve data quality and compliance on a grand scale, encompassing aspects such as onboarding multiple sites efficiently, ensuring site adoption and compliance, promoting patient-centric practices, enhancing trial efficiency, and maintaining control over the process.